Abstract:Background Observational studies suggest that adequate dietary potassium intake (90–120 mmol/day) may be renoprotective, but the effects of increasing dietary potassium and the risk of hyperkalemia are unknown. Methods This is a prespecified analysis of the run-in phase of a clinical trial in which 191 patients (age 68±11 years, 74% males, 86% European ancestry, eGFR 31±9 ml/min per 1.73 m 2 , 83% renin-angiotensin system inhibitors, 38% diabetes) were treated with 40 mmol potassium chloride (KCl) per day for 2 weeks. Results KCl supplementation significantly increased urinary potassium excretion (72±24 to 107±29 mmol/day), plasma potassium (4.3±0.5 to 4.7±0.6 mmol/L), and plasma aldosterone (281 [198–431] to 351 [241–494] ng/L), but had no significant effect on urinary sodium excretion, plasma renin, BP, eGFR, or albuminuria. Furthermore, KCl supplementation increased plasma chloride (104±3 to 105±4 mmol/L) and reduced plasma bicarbonate (24.5±3.4 to 23.7±3.5 mmol/L) and urine pH (all P <0.001), but did not change urinary ammonium excretion. In total, 21 participants (11%) developed hyperkalemia (plasma potassium 5.9±0.4 mmol/L). They were older and had higher baseline plasma potassium. Conclusions In patients with CKD stage G3b–4, increasing dietary potassium intake to recommended levels with potassium chloride supplementation raises plasma potassium by 0.4 mmol/L. This may result in hyperkalemia in older patients or those with higher baseline plasma potassium. Longer-term studies should address whether cardiorenal protection outweighs the risk of hyperkalemia. Clinical trial number: NCT03253172 Significance Statement Observational studies show health benefits from a higher potassium intake, but it is unknown if this is tolerated by patients with CKD. This 2-week study indicates that 40 mmol/day potassium chloride supplementation (the estimated gap between actual and adequate intake) increased plasma potassium by 0.4 mmol/L in 191 patients with CKD (eGFR 31 ml/min per 1.73 m 2 , 83% on renin-angiotensin inhibitors). The majority of patients (89%) remained normokalemic. Higher baseline plasma potassium and older age were risk factors for developing hyperkalemia after supplementation. Potassium chloride supplementation did not lower office BP, but did cause a tendency toward hyperchloremic metabolic acidosis. Longer-term studies should determine whether the cardiorenal benefits of adequate dietary potassium intake outweigh the risk of hyperkalemia in patients with CKD. Visual

Study on Safety and Efficacy of Concentrated Potassium Chloride Infusions in Critically Ill Patients with Hypokalemia

Evaluation of an Intravenous Potassium Dosing Algorithm for Hypokalemic Critically Ill Patients

Effects of Short-Term Potassium Chloride Supplementation in Patients with CKD

Continuous Veno-venous Hemofiltration for Emergency Treatment of Severe Hyperkalemia in ICU

Serum potassium levels and outcomes in critically ill patients in the medical intensive care unit

A quality control procedure for central venous blood sampling based on potassium concentrations

Association Between Blood Potassium Level and Recovery of Postoperative Gastrointestinal Motility During Continuous Renal Replacement Therapy in Patient Undergoing Open Abdominal Surgery

An integrative review of potassium replacement protocol use in critical care: Development, use and critical care nurse autonomy

Efficacy and safety analysis of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on rapid reduction of potassium in moderate to severe hyperkalemia patients with chronic kidney disease without dialysis

Higher Serum Chloride Concentrations Are Associated with Acute Kidney Injury in Unselected Critically Ill Patients

Implementing continuous quality improvement process in potassium management in peritoneal dialysis patients.

Optimising patient care: comprehensive evaluation of inpatient hypokalaemia

Clinical Outcomes by Serum Potassium Levels for Patients Hospitalized for Heart Failure: Secondary Analysis of Data from the China National Heart Failure Registry.

A Multicenter Study of Hemodialysis Using Individualized Dialysate Potassium Concentrations.

Determinants of hypokalemia following hypertonic sodium bicarbonate infusion

Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium

The Impact of Normal Saline or Balanced Crystalloid on Plasma Chloride Concentration and Acute Kidney Injury in Patients With Predicted Severe Acute Pancreatitis: Protocol of a Phase II, Multicenter, Stepped-Wedge, Cluster-Randomized, Controlled Trial

Cell-inspired selective potassium removal towards hyperkalemia therapy by microphase-isolated core-shell microspheres

Calcium polystyrene sulfonate in treating hyperkalemia patients with chronic kidney disease: a multi-center clinical study

Development and Validation of a Predictive Model for the Assessment of Potassium-Lowering Treatment among Hyperkalemia Patients

Randomized trial on the effect of oral potassium chloride supplementation on the thiazide-sensitive sodium chloride cotransporter in healthy adults